Cigna Group Form 4 insider transactions

Nicole S Jones, See Remarks of Cigna Group, sold 19,436 shares of common stock on August 4, 2026 for $276.27 per share.

Cigna Group Chief Accounting Officer Jamie G. Kates exercised 899 stock options and subsequently sold the shares.

Cigna Group's EVP, Global CIO, Durga Prasad Koka, reported a transaction involving the withholding of shares for tax obligations.

Cigna Group Director George Kurian reported the acquisition of phantom stock units under the company's Deferred Compensation Plan.

Cigna Group CEO David Cordani reported a series of stock transactions on May 12-13, 2026, primarily involving the sale of common stock.

Cigna Group Director Eric J. Foss acquired 782 shares of common stock on April 22, 2026.

Director Mark B. McClellan acquired 782 shares of Cigna Group common stock on April 22, 2026.

Director Neesha Hathi acquired 782 shares of Cigna Group common stock as part of a routine equity grant.

Cigna Group Director Donna F. Zarcone acquired 782 shares of common stock on April 22, 2026.

Director Kathleen Mazzarella acquired 782 shares of Cigna Group common stock on April 22, 2026.

Cigna Group Director George Kurian acquired 782 shares of common stock on April 22, 2026.

Director Kimberly A. Ross acquired 782 shares of Cigna Group common stock as part of a routine equity grant.

Director Michael J. Hennigan acquired 782 shares of Cigna Group common stock on April 22, 2026.

Director Philip Ozuah acquired 782 shares of The Cigna Group common stock as part of a routine equity grant.

Cigna Group Director Eric Wiseman acquired 782 shares of common stock on April 22, 2026, as part of a routine equity grant.

Cigna's Chief Accounting Officer, Jamie G. Kates, reported the acquisition of performance and restricted shares, along with stock options, and related tax-driven share dispositions.

Cigna's EVP, Global CIO, Durga Prasad Koka, disclosed the acquisition of common stock and stock options, alongside tax-related share dispositions, stemming from performance and restricted share settlements.

A Cigna Group officer reported the acquisition of performance shares and restricted stock, alongside tax-related disposals and a pre-planned sale of common stock.

Cigna Group officer Brian C. Evanko reported the acquisition of common stock and stock options, alongside disposals for tax obligations, reflecting performance-based awards and restricted share vesting.

Cigna Group's EVP and CFO, Ann M. Dennison, reported the acquisition of restricted stock and employee stock options, alongside a disposition of shares for tax purposes.

Cigna Group Director George Kurian acquired 103.5125 phantom stock units through a deferred compensation plan, increasing his beneficial ownership to 1,803.6672 units.

Cigna Group Director George Kurian acquired 108.1939 phantom stock units through a deferred compensation plan, increasing his beneficial ownership to 1,690.8366 units.

Cigna Group's Chairman and CEO, David Cordani, reported a purchase of 4,134 common shares and significant transfers related to his grantor retained annuity trust.

Cigna's President and COO, Brian C. Evanko, exercised stock options and subsequently sold a portion of the acquired common stock under a pre-arranged 10b5-1 trading plan.

Cigna Group Director George Kurian deferred a portion of his cash retainer into phantom stock units under the company's Deferred Compensation Plan.

Cigna's EVP and Chief Health Officer, David J. Brailer, reported a future disposition of 290 common shares on August 29, 2025, to satisfy tax obligations from restricted share vesting.

Cigna's EVP, Chief Administrative Officer and General Counsel, Nicole S. Jones, exercised stock options and sold a portion of her shares under a pre-arranged 10b5-1 trading plan.

Cigna Group Director Michael J. Hennigan has acquired 568 shares of the company's common stock, as disclosed in a recent SEC Form 4 filing.

Cigna Group Director George Kurian acquired additional phantom stock units as part of a routine deferred compensation plan, aligning his interests with shareholders.

Director Donna F. Zarcone reports acquiring 638 shares of Cigna Group common stock on April 23, 2025.